Literature DB >> 3951393

Studies on the adaptation of mumps virus to chick embryo.

H Naruse, T Morishima, S Isomura, M Hamaguchi, T Toyoda, T Yoshida, Y Nagai.   

Abstract

About 15 serial passages of wild type mumps virus (Sasazaki strain) in the amnion sac of chick embryo (CE) yielded a CE-adapted strain which was poorly replicative and did not form plaques in Vero cells where the wild strain grew well. In the course of this limited replication of the CE-adapted strain in Vero cells, we have analysed the viral protein and RNA synthesis. It was found that protein synthesis took place very efficiently at least early in infection by 12 h. The subsequent rate of synthesis remained, however, at a low level without showing the progressively increasing synthesis observed with the wild strain. Furthermore, 50S genomic RNA was synthesized early in the limited infection, but the subsequent synthesis was markedly suppressed. In addition, the other virus-specific RNA species could not be detected throughout. Thus the amplified RNA synthesis observed in the permissive CE cells and in the wild strain-infection of Vero cells seemed not to occur in the limited replication. Neither interferon nor DI (defective interfering) RNA was involved in the limited virus growth. When Vero cells were infected with the wild strain 6 to 8 h before inoculation of CE-adapted strain, growth restriction was overcome and the yield of the latter virus was greatly enhanced by a factor more than 10(3). These results suggest that through adaptation to CE, mumps virus may be altered in such a way that there is a restriction, probably at a step (s) involved in amplification of the viral RNA synthesis in Vero cells and that the restriction may be overcome by the simultaneous genome expression of the prototype wild strain.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3951393     DOI: 10.1007/bf02123682

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  14 in total

1.  Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A.

Authors:  S W Kessler
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

2.  Cytopathogenicity of mumps virus in cultures of chick embryo and human amnion cells.

Authors:  I GRESSER; J F ENDERS
Journal:  Proc Soc Exp Biol Med       Date:  1961 Aug-Sep

3.  Studies on the viral spectra of tissue culture lines of human cells.

Authors:  F DEINHARDT; G HENLE
Journal:  J Immunol       Date:  1957-07       Impact factor: 5.422

4.  Propagation and primary isolation of mumps virus in tissue culture.

Authors:  G HENLE; F DEINHARDT
Journal:  Proc Soc Exp Biol Med       Date:  1955-08

5.  Attenuation of virulence with retention of antigenicity of mumps virus after passage in the embryonated egg.

Authors:  J F ENDERS; J H LEVENS
Journal:  J Immunol       Date:  1946-11       Impact factor: 5.422

6.  Live attenuated mumps virus vaccine. 1. Vaccine development.

Authors:  E B Buynak; M R Hilleman
Journal:  Proc Soc Exp Biol Med       Date:  1966-12

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Persistent infection by a temperature-sensitive mutant isolated from a Sendai virus (HVJ) carrier culture: its initiation and maintenance without aid of defective interfering particles.

Authors:  T Yoshida; M Hamaguchi; H Naruse; Y Nagai
Journal:  Virology       Date:  1982-07-30       Impact factor: 3.616

9.  Mumps virus replication in chick embryo lung cells: properties of ribonucleic acids in virions and infected cells.

Authors:  J L East; D W Kingsbury
Journal:  J Virol       Date:  1971-08       Impact factor: 5.103

10.  Inhibition of virus growth by ouabain: effect of ouabain on the growth of HVJ in chick embryo cells.

Authors:  Y Nagai; K Maeno; M Iinuma; T Yoshida; T Matsumoto
Journal:  J Virol       Date:  1972-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.